These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2419379)

  • 1. Analgesia after inhibition of enkephalin degradation.
    Kehl LJ
    J Am Dent Assoc; 1986 Feb; 112(2):181-3. PubMed ID: 2419379
    [No Abstract]   [Full Text] [Related]  

  • 2. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase A.
    Chipkin RE; Iorio LC; Barnett A; Berger J; Billard W
    Adv Biochem Psychopharmacol; 1982; 33():235-42. PubMed ID: 6751031
    [No Abstract]   [Full Text] [Related]  

  • 4. Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens.
    Blum K; Wallace JE; DeLallo L; Briggs AH
    Funct Neurol; 1986; 1(2):156-64. PubMed ID: 3301556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility).
    Nabeshima T; Katoh A; Kameyama T
    J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of enkephalins degradation in the nucleus accumbens leads to potentiation of acupuncture and morphine analgesia].
    Jin WQ; Zhou ZF; Han JS
    Sheng Li Xue Bao; 1985 Aug; 37(4):377-82. PubMed ID: 3915599
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of peptidase inhibitors on methionine5-enkephalin-arginine6-phenylalanine7 (YGGFMRF) and methionine5-enkephalin (YGGFM) metabolism and on electroacupuncture antinociception.
    Chou J; Tang J; Del Rio J; Yang HY; Costa E
    J Pharmacol Exp Ther; 1984 Aug; 230(2):349-52. PubMed ID: 6205138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
    Roques BP
    J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiorphan potentiation of stress-induced analgesia in the mouse.
    Greenberg R; O'Keefe EH
    Life Sci; 1982 Sep 20-27; 31(12-13):1185-8. PubMed ID: 6755120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opioid peptides: metabolism and receptors].
    Giros B; Gros C; Llorens-Cortes C; Schwartz JC
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):7B-13B. PubMed ID: 3038654
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin.
    Llorens-Cortes C; Schwartz JC
    Eur J Pharmacol; 1984 Sep; 104(3-4):369-74. PubMed ID: 6594244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of exogenous enkephalin in the guinea-pig ileum: relative importance of aminopeptidase, enkephalinase and angiotensin converting enzyme activity.
    Geary LE; Wiley KS; Scott WL; Cohen ML
    J Pharmacol Exp Ther; 1982 Apr; 221(1):104-11. PubMed ID: 6278132
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan.
    Chipkin RE; Latranyi MZ; Iorio LC; Barnett A
    Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidases involved in the inactivation of exogenous and endogenous enkephalins.
    Schwartz JC; de la Baume S; Yi CC; Chaillet P; Marcais-Collado H; Costentin J
    J Neural Transm Suppl; 1983; 18():235-43. PubMed ID: 6348211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone.
    Chipkin RE; Latranyi MB; Iorio LC
    Life Sci; 1982 Sep 20-27; 31(12-13):1189-92. PubMed ID: 6958954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thiorphan on the antinociceptive actions of intrathecal [D-Ala2,Met5] enkephalin.
    Yaksh TL; Harty GJ
    Eur J Pharmacol; 1982 Apr; 79(3-4):293-300. PubMed ID: 7047177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.